PofoliaPofolia ile paylaşıldı

BMC Oral Health· 2026Q1

Rino-maksiller mukormikoz yönetiminde algoritmaya dayalı yaklaşım: iki bölümlük çalışmanın II. bölümü

Algorithm-based approach to the management of rhino-maxillary mucormycosis: part II of a two-part study

Samir Ali Elborolosy, Ghada Amin Khalifa, Kamal Ebeid, Hamada Mahran ve diğerleri

Kısa özet

Rino-maksiller mukormikozun (RMM) daha erken teşhisi, hastalık gerilemesi ve olumlu iyileşme modelleri ile anlamlı derecede ilişkilidir ve en güçlü ilişki ameliyat sonrası üçüncü ayda gözlemlenmiştir (χ² = 17.47, Cramer’s V = 0.56, p = 0.008).

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • RMM'nin daha erken teşhisi (4-7 gün), hastalık gerilemesi ve olumlu iyileşme modelleri ile anlamlı derecede ilişkilidir.
  • Teşhis zamanlaması ile sonuçlar arasındaki en güçlü ilişki ameliyat sonrası üçüncü ayda gözlemlenmiştir (gerileme için p = 0.008, iyileşme için p = 0.0004).
  • Çalışma, Kasım 2019 ile Aralık 2021 tarihleri arasında tedavi edilen 30 RMM hastasını analiz etmiş ve genel sağkalım oranı %83.33'tür.
  • Erken triyaj ve koordineli multidisipliner müdahaleyi kolaylaştırmak için yapılandırılmış bir teşhis ve yönetim algoritması önerilmektedir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

Rhino-maxillary mucormycosis (RMM) is an aggressive, life-threatening fungal infection associated with substantial morbidity and mortality. While early diagnosis is universally advocated, robust quantitative evidence delineating how defined diagnostic delays influence objective clinical outcomes remains scarce. This study aimed to quantify the relationship between diagnostic timing and treatment outcomes in RMM and to develop a protocol-driven multidisciplinary algorithm to standardize management. This retrospective case series analyzed patients diagnosed and treated for RMM at the Otolaryngology and Oral and Maxillofacial Surgery clinics of Beni-Suef University between November 2019 and December 2021. Data extraction and statistical analysis were conducted from June 2022 to January 2024. Diagnostic timing was categorized as early (4–7 days), late (8–10 days), or delayed (> 10 days). Primary outcomes included disease prognosis (regression, stabilization, progression, or death) and resolution pattern (favorable or unfavorable). Associations were evaluated using chi-square tests and Cramer’s V, with statistical significance set at p < 0.05. Thirty patients were included (mean age 56.53 ± 11.52 years; 60% male). Early diagnosis occurred in 40% of cases, late in 26.67%, and delayed in 33.33%. The overall survival rate was 83.33%. At final follow-up, disease regression was observed in 60% of patients, stabilization in 16.67%, and progression in 6.67%. A statistically significant association was identified between diagnostic timing and disease regression across follow-up intervals, most pronounced at the third postoperative month (χ 2 = 17.47, Cramer’s V = 0.56, p = 0.008). Diagnostic timing was also significantly associated with a favorable resolution pattern at the third month (χ 2 = 15.77, Cramer’s V = 0.75, p = 0.0004). This association was not statistically significant at six months ( p = 0.87). Diagnostic timing demonstrates a significant association with clinical outcomes in RMM. Earlier diagnosis correlates with higher rates of regression and favorable resolution patterns. Adoption of a structured diagnostic and management algorithm may facilitate early triage and coordinated multidisciplinary intervention, contributing to improved outcome standardization in oral and maxillofacial practice. Prospective validation in larger cohorts is warranted.

Yazarların özeti; kaynağından alınmıştır. BMC Oral Health, 2026 · DOI ↗

ÇıkarımlarUygulamada
Makaleye SorUygulamada

Devamı Pofolia uygulamasında

Çıkarımlar ve makaleye soru sorma; ilgi alanına göre her gün yeni özetler. Ücretsiz.

Web'de giriş yaparak aç

Alan: Enfeksiyon Hastalıkları

Infectious DiseasesMedicine